Feature Channels:

Blood Disorders

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Acute Promyelocytic Leukemia, Immune Cells, immune suppression, Prostate Cancer

Ludwig Scientists Discover Complex Axis of Immune Suppression Exploited by Cancers

A Ludwig Cancer Research study has uncovered a new mechanism by which cancer cells evade destruction by the immune system. The paper, led by Camilla Jandus of the Lausanne Branch of the Ludwig Institute for Cancer Research, describes how immune cells known as group 2 innate lymphoid cells (ILC2s) are recruited by leukemic cells to suppress an essential anticancer immune response.

Medicine

Channels:

Brain Tumor, Blood Brain Barrier (BBB), Parkinson Disease Treatment, Dementia, Drugs and the Brain

New Model May Help Science Overcome the Brain’s Fortress-Like Barrier

MAHERALLY-BBB.jpg

Scientists have helped provide a way to better understand how to enable drugs to enter the brain and how cancer cells make it past the blood brain barrier.

Medicine

Life

Social and Behavioral Sciences

Channels:

Brandon’s Book Released – Going the Distance

join-team-brandon-150x1142x.png

Brandon Hudgins, professional long-distance runner, GPA/Wegener’s patient and leader of VF Team Brandon, has shared his story in his recently released book, “Going the Distance: The Journey of a Vasculitis Patient on the Road to Olympic Glory.”

Medicine

Channels:

Yale Cancer Center, Thyroid Cancer, American Association For Cancer Research, Cancer Research

Lower Thyroid Stimulating Hormone Levels Elevate Risk of Thyroid Cancer, Yale Study Finds

thyroid.jpg

There is an increased risk of thyroid cancer associated with lower-than-normal thyroid hormone levels, a finding that could have a major impact on patients fighting the disease.

Medicine

Channels:

Leukemia, Immunotherapy, CAR T-cell therapy

Monroe Carell Jr. Children’s Hospital at Vanderbilt to Offer New Cutting-Edge Treatment for Type of Pediatric Leukemia

Monroe Carell Jr. Children’s Hospital at Vanderbilt is part of a select group of health care institutions recently chosen to offer a new FDA-approved immunotherapy for a subset of pediatric acute lymphoblastic leukemia (ALL).

Medicine

Channels:

Magnesium

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 20-Sep-2017 4:00 PM EDT

Medicine

Channels:

Bone Marrow Transplant, Leukemia, Acute Lymphoblastic Leukemia, All

Leukemia Patient Meets Donor Who Saved His Life

JeffreyHoffmanleftandZacharyGold.jpg

Leukemia survivor Jeffrey Hoffman owes his life to a complete stranger who altruistically donated bone marrow cells for Mr. Hoffman's successful bone marrow transplant. "It was a very noble thing to do," Mr. Hoffman said. On September 10, 2017, Mr. Hoffman (left) met his donor, Zachary Gold (right), for the first time, during Loyola Medicine's Bone Marrow TransplantCelebration of Survivorship. About 400 patients, family members, caregivers, donors, doctors and nurses attended the annual event at Loyola’s Cardinal Bernardin Cancer Center.

Medicine

Channels:

Lupus, Kidney transplantation, kidney donors,

Kidney Transplants Are Lifesaving for Some Lupus Patients

DarrasAward.JPG

Medicine

Channels:

Leukemia, AML acute myeloid leukemia

MD Anderson and Daiichi Sankyo Enter Research Collaboration to Accelerate Development of Acute Myeloid Leukemia Therapies

The University of Texas MD Anderson Cancer Center and Daiichi Sankyo Company, Limited today announced a multi-year collaboration focused on accelerating the development of novel therapies for acute myeloid leukemia (AML).

Medicine

Channels:

Levofloxacin, acute lymphoblastic leukemia (ALL) , Antibacterial, Prophylaxis, leukemia treatment, Antibiotic Therapy, Infection Control

Antibiotic Identified That Reduces Infection Risk in Young Leukemia Patients

00195242-014.jpg

St. Jude Children’s Research Hospital investigators report preventive antibiotic therapy, particularly with levofloxacin, reduced the odds of infections in at-risk pediatric leukemia patients early in cancer treatment







Chat now!